Home
PB Ratio of Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Ltd
NSE: EMCURE
PB Ratio
Key Highlights
- The latest PB Ratio of Emcure Pharmaceuticals Ltd is 4.9.
- The PB ratio of the Emcure Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
- The P/B Ratio of Emcure Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
Historical P/B Ratio of Emcure Pharmaceuticals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Emcure Pharmaceuticals Ltd
Company Fundamentals for Emcure Pharmaceuticals Ltd
Market Cap
20,393 Cr
EPS
32.1
P/E Ratio (TTM)
33.6
P/B Ratio (TTM)
4.9
Day’s High
1095.8
Day’s Low
1049.5
DTE
0.3
ROE
13.8
52 Week High
1577.5
52 Week Low
911.75
ROCE
18.7
Market Price of Emcure Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
01 Apr 2025 | 1076.55 |
28 Mar 2025 | 1072.8 |
27 Mar 2025 | 1046.15 |
26 Mar 2025 | 1024.65 |
25 Mar 2025 | 1006.45 |
24 Mar 2025 | 1061.75 |
21 Mar 2025 | 1029 |
20 Mar 2025 | 1001.05 |
19 Mar 2025 | 932.45 |
18 Mar 2025 | 937.7 |
SWOT Analysis
BlinkX Score for Emcure Pharmaceuticals Ltd
Asset Value vs Market Value of Emcure Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
Company | PB | Market Cap |
---|
Emcure Pharmaceuticals Ltd | 4.95 | 20393 |
Sun Pharmaceutical Industries Ltd | 99.3 | 407155 |
Divis Laboratories Ltd | 524.3 | 147295 |
Cipla Ltd | 362.8 | 116664 |
Torrent Pharmaceuticals Ltd | 224.3 | 107673 |
Company | |
---|---|
Emcure Pharmaceuticals Ltd | 4.95 |
Sun Pharmaceutical Industries Ltd | 99.3 |
Divis Laboratories Ltd | 524.3 |
Cipla Ltd | 362.8 |
Torrent Pharmaceuticals Ltd | 224.3 |
PB Ratio of Emcure Pharmaceuticals Ltd Explained
₹20393
Market cap
₹217
Book Value per Share
4.9X
PB Ratio
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.
How to calculate Price-to-Book (P/B) Ratio?
The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.
Market capitalization = market value of a stock X no. of outstanding shares
Now, you need to know the net value of an organization's assets.
Book Value of Assets = Total Assets - Total Liabilities of a company
After knowing the value of the above ratios, here is the formula for the P/B Ratio:
P/B Ratio = Market Capitalization/ Book Value of Assets
or you can also use this formula
P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical Market Cap of Emcure Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Emcure Pharmaceuticals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Emcure Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Emcure Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Emcure Pharmaceuticals Ltd News Hub
Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs
Read more
13 Aug 24
Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank
Read more
13 Aug 24
Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter
Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Emcure Pharmaceuticals to declare Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202
Read more
10 Aug 24